ScholarIQanswers from OpenAlex & ORCID
James E. Balow
ResearcherPublications, citations & collaboration network
James E. Balow is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James E. Balow have?
ScholarIQindexed works
James E. Balow has 199 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James E. Balow have?
ScholarIQcitation count
James E. Balow has 21,985 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James E. Balow?
ScholarIQh-index
James E. Balow has an h-index of 63 in OpenAlex.
What is the i10-index of James E. Balow?
ScholarIQi10-index
James E. Balow has an i10-index of 136 in OpenAlex.
What is the OpenAlex record for James E. Balow?
ScholarIQopenalex
The OpenAlex for James E. Balow is on the source record.
What are the most-cited papers on James E. Balow?
ScholarIQmost cited works
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Jan J. Weening, Vivette D. D’Agati, Melvin M. Schwartz, Surya V. Seshan, Charles E. Alpers, Gerald B. Appel, James E. Balow, Jan A. Bruijn, Terence Cook, Franco Ferrario, Agnes B. Fogo, Ellen M. Ginzler, Lee A. Hebert, Gary S. Hill, Prue Hill, J. Charles Jennette, Norella Kong, Philippe Lesavre, Michael D. Lockshin, Lai‐Meng Looi, Hirofumi Makino, Luiz A. Moura, Michio Nagata
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Jan J. Weening, ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis, Vivette D. D’Agati, Melvin M. Schwartz, Surya V. Seshan, Charles E. Alpers, Gerald B. Appel, James E. Balow, Jan A. Bruijn, Terence Cook, Franco Ferrario, Agnes B. Fogo, Ellen M. Ginzler, L Hebert, Gary S. Hill, Prue Hill, J. Charles Jennette, Norella Kong, Philippe Lesavre, Michael D. Lockshin, Lai‐Meng Looi, Hirofumi Makino, Luiz A. Moura, Michio Nagata
Enzyme Replacement Therapy in Fabry Disease
Raphael Schiffmann, Jeffrey B. Kopp, Howard A. Austin, Sharda G. Sabnis, David F. Moore, Thais Weibel, James E. Balow, Roscoe O. Brady
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis
Dimitrios T. Boumpas, H A Austin, James E. Balow, Ellen M. Vaughan, Cheryl Yarboro, John H. Klippel, A D Steinberg
A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis
Dimitrios T. Boumpas, Richard Furie, Susan Manzi, Gabor G. Illei, Daniel J. Wallace, James E. Balow, Akshay Vaishnaw, on behalf of the BG9588 Lupus Nephritis Trial Group